SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+4.47%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$425M
AUM Growth
+$425M
(-15%)
Cap. Flow
-$89.8M
Cap. Flow
% of AUM
-21.12%
Top 10 Holdings %
Top 10 Hldgs %
54.69%
Holding
34
New
5
Increased
6
Reduced
22
Closed
1
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$10M |
| 2 |
Cigna
CI
|
$9.53M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$8.58M |
| 4 |
Incyte
INCY
|
$5.59M |
| 5 |
BioNTech
BNTX
|
$3.36M |
Top Sells
| 1 |
Merck
MRK
|
$25.8M |
| 2 |
Pfizer
PFE
|
$21.6M |
| 3 |
Baxter International
BAX
|
$19.1M |
| 4 |
Dentsply Sirona
XRAY
|
$7.62M |
| 5 |
Qiagen
QGEN
|
$7.41M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merck
MRK
$210B
| $36.5M | 8.57% | 475,804 -337,010 | -41% | -$25.8M |
|
|
2
Incyte
INCY
$16.5B
| $27.8M | 6.54% | 378,852 +76,113 | +25% | +$5.59M |
|
3
Cardinal Health
CAH
$35.5B
| $25.6M | 6.01% | 496,680 -26,926 | -5% | -$1.39M |
|
4
Bristol-Myers Squibb
BMY
$96B
| $21.7M | 5.11% | 348,591 -96,419 | -22% | -$6.01M |
|
5
Gilead Sciences
GILD
$140B
| $21.6M | 5.07% | 297,055 -74,030 | -20% | -$5.38M |
|
6
CVS Health
CVS
$92.8B
| $21.3M | 5% | 206,162 +30,042 | +17% | +$3.1M |
|
7
Boston Scientific
BSX
$156B
| $21.2M | 4.99% | 499,530 -103,152 | -17% | -$4.38M |
|
8
Medtronic
MDT
$119B
| $21.1M | 4.97% | 204,268 +19,568 | +11% | +$2.02M |
|
9
Becton Dickinson
BDX
$55.3B
| $19M | 4.47% | 75,647 -5,946 | -7% | -$1.5M |
|
|
10
Pfizer
PFE
$141B
| $16.9M | 3.96% | 285,403 -366,197 | -56% | -$21.6M |
|
11
Biogen
BIIB
$19.4B
| $16M | 3.76% | 66,599 -16,720 | -20% | -$4.01M |
|
12
Elevance Health
ELV
$71.8B
| $15.9M | 3.75% | 34,402 -8,790 | -20% | -$4.07M |
|
13
Centene
CNC
$14.3B
| $15.1M | 3.55% | 183,146 -29,077 | -14% | -$2.4M |
|
14
Bruker
BRKR
$5.16B
| $13.7M | 3.21% | 162,768 -70,484 | -30% | -$5.91M |
|
15
Organon & Co
OGN
$2.45B
| $13.1M | 3.09% | 431,709 -114,353 | -21% | -$3.48M |
|
|
NUVA
16
DELISTED
NuVasive, Inc.
NUVA
| $12.6M | 2.97% | 240,691 -57,735 | -19% | -$3.03M |
|
|
17
Qiagen
QGEN
$10.1B
| $10.9M | 2.57% | 196,845 -133,375 | -40% | -$7.41M |
|
|
18
BioMarin Pharmaceuticals
BMRN
$11.2B
| $10M | 2.36% | +113,548 | New | +$10M |
|
19
Elanco Animal Health
ELAN
$9.12B
| $9.8M | 2.3% | 345,230 -64,501 | -16% | -$1.83M |
|
|
20
Cigna
CI
$80.3B
| $9.53M | 2.24% | +41,500 | New | +$9.53M |
|
21
Bio-Rad Laboratories Class A
BIO
$8.06B
| $8.79M | 2.07% | 11,639 +384 | +3% | +$290K |
|
|
22
Vertex Pharmaceuticals
VRTX
$100B
| $8.58M | 2.02% | +39,069 | New | +$8.58M |
|
23
Labcorp
LH
$23.1B
| $7.35M | 1.73% | 23,377 -14,481 | -38% | -$4.55M |
|
|
24
Dentsply Sirona
XRAY
$2.85B
| $6.41M | 1.51% | 114,816 -136,514 | -54% | -$7.62M |
|
25
Ionis Pharmaceuticals
IONS
$6.79B
| $6.38M | 1.5% | 209,537 -54,333 | -21% | -$1.65M |
|